193 related articles for article (PubMed ID: 27192044)
1. Gestation related karyotype, QF-PCR and CGH-array failure rates in diagnostic amniocentesis.
Lawin O'Brien A; Dall'Asta A; Tapon D; Mann K; Ahn JW; Ellis R; Ogilvie C; Lees C
Prenat Diagn; 2016 Aug; 36(8):708-13. PubMed ID: 27192044
[TBL] [Abstract][Full Text] [Related]
2. Detection of mosaicism for primary trisomies in prenatal samples by QF-PCR and karyotype analysis.
Donaghue C; Mann K; Docherty Z; Ogilvie CM
Prenat Diagn; 2005 Jan; 25(1):65-72. PubMed ID: 15662691
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of the BACs-on-Beads™ assay versus karyotyping for prenatal detection of chromosomal abnormalities: a retrospective consecutive case series.
Choy KW; Kwok YK; Cheng YK; Wong KM; Wong HK; Leung KO; Suen KW; Adler K; Wang CC; Lau TK; Schermer MJ; Lao TT; Leung TY
BJOG; 2014 Sep; 121(10):1245-52. PubMed ID: 24893808
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of fetuses with increased nuchal translucency using an approach based on quantitative fluorescent polymerase chain reaction and genomic microarray.
Pan M; Han J; Zhen L; Yang X; Li R; Liao C; Li DZ
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():164-7. PubMed ID: 26771907
[TBL] [Abstract][Full Text] [Related]
5. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of quantitative fluorescence PCR analysis in high-risk pregnancies after combined first-trimester screening.
Lildballe DL; Vogel I; Petersen OB; Vestergaard EM
Dan Med J; 2014 Nov; 61(11):A4964. PubMed ID: 25370964
[TBL] [Abstract][Full Text] [Related]
7. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 7 mosaicism at amniocentesis: interphase FISH, QF-PCR, and aCGH analyses on uncultured amniocytes for rapid distinguishing of true mosaicism from pseudomosaicism.
Chen CP; Huang HK; Su YN; Chern SR; Su JW; Lee CC; Town DD; Chen WL; Chen YT; Wang W
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):77-82. PubMed ID: 22482973
[TBL] [Abstract][Full Text] [Related]
9. [Rapid detection of the most common chromosomal aneuploidies in the second-trimester amniotic fluid using QF-PCR].
Švecová I; Burjanivová T; Kršiaková J; Lasabová Z; Biringer K; Kapustová I; Móricová P; Danko J
Ceska Gynekol; 2013 Aug; 78(4):373-8. PubMed ID: 24040987
[TBL] [Abstract][Full Text] [Related]
10. Application of non-invasive prenatal testing in late gestation in a pregnancy associated with intrauterine growth restriction and trisomy 22 confined placental mosaicism.
Chen CP; Tsai C; Lin MH; Chern SR; Chen SW; Lai ST; Chen WL; Pan CW; Wang W
Taiwan J Obstet Gynecol; 2017 Oct; 56(5):691-693. PubMed ID: 29037560
[TBL] [Abstract][Full Text] [Related]
11. [Edwards syndrome--most frequent indications for genetic amniocentesis. Analysis of the last 5 years].
Chuchracki M; Janiak J; Ziółkowska K; Sedziak A; Opala T
Przegl Lek; 2012; 69(10):1007-10. PubMed ID: 23421080
[TBL] [Abstract][Full Text] [Related]
12. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
13. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
14. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
Langlois S; Duncan A; ;
J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing.
Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P
Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of mosaic trisomy 8: clinical report and literature review.
Chen CP; Chen M; Pan YJ; Su YN; Chern SR; Tsai FJ; Chen YT; Wang W
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):331-8. PubMed ID: 22030049
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis.
Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627
[TBL] [Abstract][Full Text] [Related]
18. Prenatal diagnosis of trisomy 21, 18 and 13 by quantitative pyrosequencing of segmental duplications.
Tong H; Jin Y; Xu Y; Zou B; Ye H; Wu H; Kumar S; Pitman JL; Zhou G; Song Q
Clin Genet; 2016 Nov; 90(5):451-455. PubMed ID: 26948280
[TBL] [Abstract][Full Text] [Related]
19. IONA test for first-trimester detection of trisomies 21, 18 and 13.
Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
[TBL] [Abstract][Full Text] [Related]
20. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
